Immediate Impact
1 standout
Citing Papers
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
2022 Standout
Works of V. Moroz being referenced
Bevacizumab for children with relapsed & refractory high-risk neuroblastoma (RR-HRNB): Results of the BEACON-neuroblastoma randomized phase II trial - A European ITCC-SIOPEN trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| V. Moroz | 30 | 60 | 1 | 24 | 9 | 74 | |
| Bharat Thakkar | 23 | 24 | 1 | 7 | 8 | 77 | |
| Riinu Pius | 25 | 76 | 58 | 6 | 9 | 166 | |
| Nils Hanke | 21 | 51 | 54 | 24 | 10 | 173 | |
| Juha Hartikainen | 20 | 36 | 15 | 8 | 10 | 109 | |
| Fatma Narter | 42 | 17 | 3 | 56 | 13 | 76 | |
| Aleksandra Paripović | 40 | 54 | 45 | 61 | 12 | 164 | |
| Melissa Crenshaw | 35 | 23 | 11 | 10 | 75 | ||
| Elizabeth Lemos Silveira | 6 | 120 | 13 | 7 | 178 | ||
| Alison Matsunaga | 15 | 29 | 1 | 40 | 7 | 174 | |
| Eswari Vilayur | 19 | 29 | 57 | 8 | 12 | 165 |
All Works
Login with ORCID to disown or claim papers
Loading papers...